Approval · Notice of Compliance 27902 · 2022
TECTA: Notice of Compliance 27902
Issued April 1, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27902
- Date
- April 1, 2022
- Company
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the Product Monograph (PM) in response to an Advisement Letter, and the PM was updated to the 2020 Master Template.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TECTA | Not yet assigned | — |
Medicinal ingredients
- PANTOPRAZOLE MAGNESIUM 40 MG per TAB